Macrolide-Resistant Shigella sonnei

Shigella sonnei UCN59, isolated during an outbreak of S. sonnei in January 2007, was resistant to azithromycin (MIC 64 mg/L). The isolate contained a plasmid-borne mph(A) gene encoding a macrolide 2′-phosphotransferase that inactivates macrolides. Emergence of the mph(A) gene in S. sonnei may limit usefulness of azithromycin for treatment of shigellosis

Mécanismes émergents de résistance bactérienne aux inhibiteurs de synthèse protéique

CAEN-BU Médecine pharmacie (141182102) / SudocSudocFranceF

Resistance to macrolides by ribosomal mutation in clinical isolates of Turicella otitidis

International audienceThe genetic basis of erythromycin resistance in , a coryneform bacteria associated with otitis, was studied in five macrolide-resistant clinical isolates. Macrolide resistance genes were searched for by polymerase chain reaction (PCR). Genes for domain V of 23S rRNA () as well as (L4 protein) and (L22 protein) genes were characterised, amplified by PCR from total genomic DNA and sequenced. In the resistant isolates, cross-resistance to macrolides and clindamycin was associated with mutations at positions 2058 and/or 2059 ( numbering). Three isolates displayed A2058 mutations, one isolate had an A2059G mutation whereas another one contained mutations at positions 2058 and 2059. Southern blot experiments revealed that had three copies of the gene. In conclusion, resistance to macrolides in is due, at least in part, to mutations in the gene